Advances in Cerebral Dysfunction in Hepatic Encephalopathy

Embed Size (px)

Citation preview

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    1/50

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    2/50

    nderstandingnderstandingerebral Dysfunctionerebral Dysfunctionnn epaticepaticEncephalopathyncephalopathy

    By

    Dr Junaid SaleemConsultant Physician

    Special Interest: Liver Disorders

    Hearts International Hospital

    Rawalpindi

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    3/50

    Presentation At A GlanceDefinition(s)Preconditions to be met for

    Development of HepaticEncephalopathy (HE)

    Precipitating Factors

    Cerebral and Neuronal DysfunctionsBiochemical Abnormalities and

    Advances in Diagnostic Imaging

    Techniques

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    4/50

    ( )efinition s)efinition s

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    5/50

    DefinitionHepatic Encephalopathy reflects aspectrum of neuropsychiatricabnormalities seen in patients withliver dysfunction after exclusion ofother known brain diseases.

    . , . , . , Working Group of WCOG Final Report Hepatology Vol 35 No 3 2002

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    6/50

    DefinitionHepatic encephalopathy is apotentially reversible syndrome ofglobal cerebral dysfunction observedin patients with liver diseases(reduced liver mass) or porto-systemic shunting, characterized by:

    Personality changesIntellectual impairment

    Depressed level of consciousness

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    7/50

    reconditions toreconditions toe met fore met for evelopment ofevelopment of

    epaticepaticEncephalopathyncephalopathy

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    8/50

    Preconditions to be metfor Development ofHepatic Encephalopathy

    1.Reduced Liver Mass< 25 30 % of Functional Liver

    Unable to deal with the Gut derivedNitrogen Load

    Passes through, but is not Detoxified /Metabolized

    2.Porto-Systemic ShuntsBypassing Liver

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    9/50

    Liver DiseasesAcuteAcute Liver Failure (ALF) Fulminant

    Hepatic Failure (FHF)

    ChronicChronic Hepatitis

    Cirrhosis

    Cholestatic liver DiseaseWilsons Disease

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    10/50

    Porto-Systemic Shunts

    (PSSs)Congenital or acquired vascularabnormalities

    Single or multiple vascular bypasschannels

    Permit portal blood flow to bypass theliver and enter the systemic circulationdirectly.

    Neurotoxic substances get a direct accessto the CNS

    Hepatic Encephalopathy

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    11/50

    o te n tia l-o rto yste m icS h u n ts1.Under the

    Diaphragm

    2.LowerEsophagus

    3.AbdominalWall

    4.Colon andRectum

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    12/50

    ( :// . /ttp maxshouse com portosystemic_shunts. )pathogenesis_and_pathophysiology htm

    Liver

    Spleenortal Vein

    Shunt

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    13/50

    Iatrogenic ShuntsTIPS Surgical Shunts

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    14/50

    epaticEncephalopaty MechanismGut DerivedNitrogenousMaterialBypasses LiverVia Shunts andReaches theBrain Directly

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    15/50

    recipitatingrecipitatingFactorsactors

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    16/50

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    17/50

    epatic Encephalopathyxacerbating factors

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    18/50

    erebral anderebral andeuronaleuronalDysfunctionsysfunctions

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    19/50

    Pathogenesis

    Multifarious toxins Dysfunction of CNS

    (No obvious morphological change)

    Several hypotheses touncover the mystery

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    20/50

    Cerebral and Neuronal

    DysfunctionsAstro-glial edema and resultant:Selective alterations of blood-brain barrier

    permeability

    Changes in cerebral energy metabolismAlterations of gene expression. e.g.

    Mono-amine oxidasePeripheral-type benzodiazepine receptor

    (PTBR)Neuronal NO synthetase

    Changes in neurotransmitter systems (Falseneurotransmitters)

    . .Butterworth RF Complications of cirrhosis III Hepa

    .encephalopathy , ; : - J Hepatol 2000 32 171 180

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    21/50

    Neuronal Dysfunctions

    Role of AstrocytesImportant constituents of the blood-brainbarrier

    Transastrocytic transport.

    Communicate directly with neuronsRegulate neurotransmitter processing

    Regulate ionic milieu

    Provide substrates for neurons

    Only cells in brain containing glutaminesynthetase

    Major site of cerebral ammonia detoxification

    Upon exposure to ammonia, culturedastrocytes develop Alzheimer type II.Stephan vom Dahl et L Hepatic encephalopathy as a complicati.of liver Disease , ; ( ): - World J Gastroentero 2001 7 2 152 156

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    22/50

    Role of AstrocytesPathophysiology of both acute or chronicliver failure is similar, but different kinetics.

    In ALF/ FHF and High Grade HE associate withCLD astrocytes swell cerebral edema

    In Low Grade HE (0-I) no clinical signs of

    cerebral edema, but evidence of increasedcell hydration

    A disturbance of astrocyte hydration is

    apparently a major pathophysiologic event

    in both forms. .Stephan vom Dahl et L Hepatic encephalopathy as acomplication-

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    23/50

    Increase Permeability of

    Blood-Brain BarrierAstrocyte (glialcell) volume iscontrolled byintracellular

    organic osmolyte-glutamine.

    Glutamine levels

    in the brain resultin volume offluid withinastrocytes

    cerebral edema

    Neurological =Normal Astrocytes

    =lz Alzheimer type IIstrocytes ale enlarged nuclei

    rominent nucleoli argination of chromatin

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    24/50

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    25/50

    ffects of Increased AstrocyticHydration

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    26/50

    iochemicaliochemicalAbnormalitiesbnormalities

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    27/50

    Pathogenesis TheoriesEndogenous Neurotoxins

    AmmoniaMercaptansPhenolsShort-medium fatty acids

    Change in Neurotransmitters andReceptors

    An increased GABA-ergic toneAltered BCAA/AAA ratio

    False NeurotransmittersOther

    Zinc deficiencyManganese deposits

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    28/50

    Pathogenesis Theories:

    Ammonia HypothesisAmmonia enters the bloodstream as aresult of its absorption from the GI tractand its liberation from kidney andmuscle cells.

    Ammonia accumulates because damaged

    liver cells fail to detoxify and convert tourea the ammonia that is constantly

    entering the bloodstream.The increased ammonia concentration in

    the blood causes brain dysfunction anddamage, resulting in hepatic

    encephalopathy.

    N t i A ti f

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    29/50

    Neurotoxic Action ofAmmoniaReadily crosses blood-brain barrier

    Increased NH3 increased glutamate

    -ketoglutarate + NH3 + NADH glutamate + NAD

    glutamate + NH3 + ATP glutamine +ADP + Pi

    As -ketoglutarate is depleted TCA cycleactivity halted decreased cellular energy

    productionIncreased glutamine formation depletes

    glutamate stores which are needed byneural tissue

    Irrepairable cell damage and neural cell

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    30/50

    Pathogenesis Theories:

    Ammonia HypothesisThe largest source of ammonia isthe enzymatic and bacterialdigestion of dietary and bloodproteins in the GI tract as aresult of:GI bleeding

    High-protein dietBacterial infectionsUremia

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    31/50

    Pathogenesis Theories:

    Ammonia HypothesisThe ingestion of ammonium salts

    also increases the bloodammonia level.

    Increased ammonia absorption

    from the GI tract and from the

    renal tubular fluid in:AlkalosisHypokalemia

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    32/50

    Pathogenesis Theories:

    Ammonia HypothesisConversely, serum ammonia is decreasedby:elimination of protein from the diet

    administration of antibiotic agents thatreduce the number of intestinalbacteria capable of converting urea toammonia, such as:

    Neomycin sulfate Metronidazole

    Rifaximin

    , . .Nathan M et al Rifaximin Treatment in Hepatic Encephalopathy N Engl J Med 36

    Ne roto ic Action of

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    33/50

    Neurotoxic Action ofAmmoniaReadily crosses blood-brain barrierIncreased NH3 increased glutamate

    -ketoglutarate + NH3 + NADH glutamate + NAD

    glutamate + NH3 + ATP glutamine +ADP + Pi

    As -ketoglutarate is depleted TCA cycleactivity halted decreased cellular energy

    productionIncreased glutamine formation depletes

    glutamate stores which are needed byneural tissue

    Irrepairable cell damage and neural cell

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    34/50

    Pathogenesis Theories:Change In Neurotransmitters and Receptors

    BCAA-Ammonia Connection

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    35/50

    Pathogenesis Theories:False Neurotransmitter

    HypothesisLiver cirrhosis characterized by altered

    amino acid metabolismIncreased Aromatic Amino Acids

    (AAA) in plasma and influx in brain

    Decrease in plasma Branched ChainAmino Acids (BCAA)

    Share a common carrier at blood-brain barrier

    BCAAs in blood may result in AAAtransport to brain

    P th i Th i

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    36/50

    Pathogenesis Theories:False Neurotransmitter HypothesisAAA are precursors to neurotransmitters andelevated levels result in shunting tosecondary pathways

    Normal Transmitter /Modulator

    Amino Acid Precursor False Neurotransmitter /Modulator

    Dopamine Tyrosine Tyramine

    Norepinephrine Tyrosine Octopamine

    ? Phenylalanine Phenethyamine

    ? Phenylalanine Phenylthanolamnine

    Serotonin (5-

    Hydroxytrptamine)

    Tryptophan ? Tryptamine

    Histamine Histidine ?

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    37/50

    Val

    :bnormal plasma amino acidshronic liver disease400

    350

    300

    250

    150

    200

    100

    50Thr

    Leu

    Ileu

    Lys

    Try

    Meth

    Phe

    Tau

    Asp

    Glu

    Ser

    Pro

    Gly

    Ala

    Tyr

    OrnHis

    Arg

    Essential Non-Essential

    %

    of

    Norm

    al

    Cerra, et al; JPEN, 1985 J. Y. Pang

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    38/50

    -ncreased GABA ergicActivitystrocyteEdema eripheral Typeenzodiazepine( )eceptors PTBRs

    ynthesis of- (euro steroids eg)llopregnenolone ABAActivity

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    39/50

    False NeurotransmitterHypothesis

    Other theories exist about the causes ofencephalopathy, including excesstryptophan and its metabolites, and

    endogenous benzodiazepines or opiates.

    Benzodiazepine-like chemicals(compounds) have been detected in the

    plasma and cerebrospinal fluid ofpatients with hepatic encephalopathydue to cirrhosis

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    40/50

    dvances indvances iniagnosticiagnosticTechniquesechniques

    euro mag ng

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    41/50

    euro mag ngTechniques

    CT ScanControversialInformation inpatients with

    cirrhosis withoutencephalopathy.

    Anatomic

    abnormalitiesattributed toatrophy and edema,correlate withneuro- psychologic

    test performance

    euro mag ng

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    42/50

    euro mag ngTechniques

    MR ImagingSymmetrical high-signalabnormalities in theglobus pallidus on T1-weighted images due to

    accumulation ofManganese (Mn)

    Generalized increase in

    white matter, limbic, andother extrapyramidalareas.

    These abnormalities

    correlate well with liver

    euro mag ng

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    43/50

    euro mag ngTechniques

    MR SpectroscopyThis technique canproduce measures ofcommon chemicals in

    the brain.

    1H-Spectra have showna characteristic

    pattern: an increasein the glutamine /glutamate peakcoupled with adecrease in the myo-

    inositol and choline,enberger J .et al Proton magnetic resonance spectroscopy of the brain in sympto

    . ; : - .asymptomatic patients with liver cirrhosis Gastroenterology 1997 112 1610 1616

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    44/50

    -H MNRspectra (A) From a healthy

    person (B) Patients with

    post hepatiticcirrhosis andlatent (subclinical)

    HE (C) Manifest grade

    I-II HE.

    An increase in the

    glutamine/glutamate signal (Glx)and a decrease ofthe inositol signal(Ino) is observed.

    Furtherabbreviations:

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    45/50

    Parietal 1H-

    MNR spectrafrom a 47-year-old patientwith alcoholic

    cirrhosis 3 daysbefore and 7days afterimplantationof TIPS, showingan increased Glxsignal and a

    decreased Ino

    euro mag ng

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    46/50

    euro mag ngTechniques

    PET ScanThis technique canprovide images ofthe brain that reflecta specific

    biochemical orphysiologic process.The exact nature of

    the image dependson the tracer used.

    PET measures ofcerebral blood flow(using 15O-water)

    Using 13N Ammoniametabolic ate can bedetermined

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    47/50

    Neuro Imaging

    TechniquesPreliminary results show that hepaticretinopathy, as detected by neuro-physiological testing, very sensitively

    reflects the degree of HE, and respondsto HE therapy.

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    48/50

    outine Labsoutine Labs

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    49/50

    Do Not Forget The

    Good OldProthrombin Time (PT)International Normalized Ratio (INR)

    Albumen

    Alanine Transaminase

    BilirubinConjugated

    UnconjugatedUrea

    Creatinine

    Fibrinogen

  • 8/9/2019 Advances in Cerebral Dysfunction in Hepatic Encephalopathy

    50/50

    hank youhank you